The top analyst upgrades, downgrades and initiations seen on Tuesday morning include Biogen, Broadcom, Devon Energy, Gilead Sciences, Mondelez and Urban Outfitters.
Stocks overall were fractionally higher early on Monday, August 29, 2016. That makes the big percentages gainers and losers and the companies with big headline news stand out even more.
24/7 Wall Street has taken a look at Mylan and a couple of other companies posting the largest losses for in the past week.
Chris Lange At this point, bad news is coming in consistently to the point that any significant piece of good news could catapult Sanofi stock higher, making it an interesting choice for dip-buyers.
Mylan is under fire for price gouging on its EpiPen. There has been some concern that this was a serious mistake by CEO Heather Bresch.
Jon C. Ogg Mylan is expected to release its second-quarter financial results after the markets close on Tuesday.
Chris Lange These are good stocks that have underperformed, make good sense in a toppy market and most likely are close to fully valued.
Ever since the infamous Hillary Clinton tweet about pharmaceutical drug pricing, the biotech and specialty pharmaceutical stocks have taken a huge beating. In some cases, the markets have knocked valuations down into…
The top analyst upgrades, downgrades and initiations seen on Friday morning include Allergan, Lockheed Martin, Mylan, Nordstrom, Petrobras, NVIDIA, Western Digital.
24/7 Wall St. is revisiting a strategy that was first published in late 2010, and then again refreshed in 2015. This is the 10 stocks to own for the decade!
A pharmaceutical company could face a threat to one of its products for a number of reasons, ranging from an improved formulation to a patent expiry and the opening of the floodgates…
24/7 Wall St. takes a look at Mylan and other companies that punished shareholders this past week.
Chris Lange Earnings season is now on the second half of its crest, and investors and traders alike are seeing serious winners and losers from each day's major earnings.
Between the December 15 and December 31 settlement dates, Intel was the most significant mover among the most heavily shorted stocks traded on the Nasdaq.
After piling on Apple in the previous period, short sellers appeared to change their minds in the heart of the holiday shopping season.
